Research Article 
Screening and management of cardiovascular risk factors in children
W. Virgil Brown, Catherine J. McNeal and Samuel S. Gidding
Journal of Clinical Lipidology, 2013, 7(5), 390-398. DOI: 10.1016/j.jacl.2013.02.001
Abstract
Not available
ASCI-ID: 2746-349
Similar Articles
Attainment of low-density lipoprotein cholesterol goals in coronary artery disease
Journal of Clinical Lipidology, 2010, 4(3), 173-180. DOI: 10.1016/j.jacl.2010.03.002
Images in cardiovascular medicine: xanthomas triggered by bile acid sequestrantsJournal of Clinical Lipidology, 2008, 2(1), 58-59. DOI: 10.1016/j.jacl.2007.12.002
Blood Cell Fatty Acid Profiles Discriminate Acute Coronary Syndrome Case Status Better than Standard Cardiovascular Risk FactorsJournal of Clinical Lipidology, 2008, 2(3), 214-217. DOI: 10.1016/j.jacl.2008.04.052
Medical management of patients before the incidence of a cardiovascular eventJournal of Clinical Lipidology, 2009, 3(5), 315-321. DOI: 10.1016/j.jacl.2009.08.002
The identification of occult cardiovascular disease through the use of a novel biomarker: a case reportJournal of Clinical Lipidology, 2009, 3(5), 351-354. DOI: 10.1016/j.jacl.2009.08.004
Assessing and addressing risk of cardiovascular disease in perimenopausal and early postmenopausal womenJournal of Clinical Lipidology, 2010, 4(5), 324-334. DOI: 10.1016/j.jacl.2010.07.006
Effect of Aggressive Cardiovascular Risk Factor Treatment on Progression of Carotid Intima-Media Thickness: Experience of an Atherosclerosis CenterJournal of Clinical Lipidology, 2012, 6(3), 262-263. DOI: 10.1016/j.jacl.2012.04.027
Cardiovascular Risk Factors in Patients Infected with HIV: Are LDL-Cholesterol and LDL-Particle Number Discordant?Journal of Clinical Lipidology, 2012, 6(3), 273-274. DOI: 10.1016/j.jacl.2012.04.046
Clinical and economic benefits observed when follow-up triglyceride levels are less than 500 mg/dL in patients with severe hypertriglyceridemiaJournal of Clinical Lipidology, 2012, 6(5), 450-461. DOI: 10.1016/j.jacl.2012.08.007
A pilot study in the efficacy and safety of gemfibrozil in a pediatric populationJournal of Clinical Lipidology, 2008, 2(2), 106-111. DOI: 10.1016/j.jacl.2008.02.003
Elevated atherogenic lipoproteins in childhood: Risk, prevention, and treatmentJournal of Clinical Lipidology, 2008, 2(3), 138-146. DOI: 10.1016/j.jacl.2008.04.006
Metabolic syndrome and dyslipidemia in youthJournal of Clinical Lipidology, 2008, 2(3), 147-155. DOI: 10.1016/j.jacl.2008.04.005
Plasma lipid profile and lipid peroxidation in beta-thalassemic childrenJournal of Clinical Lipidology, 2008, 2(6), 405-409. DOI: 10.1016/j.jacl.2008.10.008
The use of lipid-lowering drugs in childrenJournal of Clinical Lipidology, 2010, 4(6), 449-461. DOI: 10.1016/j.jacl.2010.10.003
A systematic review of bile acid sequestrant therapy in children with familial hypercholesterolemiaJournal of Clinical Lipidology, 2011, 5(2), 76-81. DOI: 10.1016/j.jacl.2011.01.005
The association of apolipoprotein E polymorphism and lipid levels in children with a family history of premature coronary artery diseaseJournal of Clinical Lipidology, 2012, 6(1), 81-87. DOI: 10.1016/j.jacl.2011.06.017
Paradoxical Relationship Between Reactive Hyperemia Index and Age in Children with Lipid DisordersJournal of Clinical Lipidology, 2012, 6(3), 271-272. DOI: 10.1016/j.jacl.2012.04.043
Integrated guidance on the care of familial hypercholesterolemia from the International FH FoundationJournal of Clinical Lipidology, 2014, 8(2), 148-172. DOI: 10.1016/j.jacl.2014.01.002
Management of familial hypercholesterolemia in children and adolescents. Position paper of the Polish Lipid Expert ForumJournal of Clinical Lipidology, 2014, 8(2), 173-180. DOI: 10.1016/j.jacl.2014.01.001
Defining the challenges of familial hypercholesterolemia screening: IntroductionJournal of Clinical Lipidology, 2010, 4(5), 342-345. DOI: 10.1016/j.jacl.2010.08.014
Integrated guidance on the care of familial hypercholesterolemia from the International FH FoundationJournal of Clinical Lipidology, 2014, 8(2), 148-172. DOI: 10.1016/j.jacl.2014.01.002
Cascade screening based on genetic testing is cost-effective: Evidence for the implementation of models of care for familial hypercholesterolemiaJournal of Clinical Lipidology, 2014, 8(4), 390-400. DOI: 10.1016/j.jacl.2014.05.008